Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
PHASE3CompletedINTERVENTIONAL
Enrollment
650
Participants
Timeline
Start Date
July 31, 2004
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
Conditions
Asthma
Interventions
DRUG
montelukast sodium
Duration of Treatment: 1 dose
DRUG
placebo
Duration of Treatment: 1 dose
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00092989 - Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) | Biotech Hunter | Biotech Hunter